Profound Medical Corp (PROF) support and resistance · rev $10.7M
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
This page maps Profound Medical Corp (PROF) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
PROF currently screens at market cap $238.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PROF 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PROF quote page for the session range and the stock page for the full model.
Not investment advice.